Multiple endocrine neoplasia type 2 differential diagnosis
|
Multiple endocrine neoplasia type 2 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Multiple endocrine neoplasia type 2 differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 differential diagnosis |
|
FDA on Multiple endocrine neoplasia type 2 differential diagnosis |
|
CDC on Multiple endocrine neoplasia type 2 differential diagnosis |
|
Multiple endocrine neoplasia type 2 differential diagnosis in the news |
|
Blogs on Multiple endocrine neoplasia type 2 differential diagnosis |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Multiple endocrine neoplasia type 2 must be differentiated from other hereditary tumors such as medullary thyroid carcinoma, C-cell hyperplasia, pheochromocytoma, von Hippel Lindau syndrome, hereditary paraganglioma-pheochromocytoma, polycythemia and paraganglioma/pheochromocytoma syndrome, neurofibromatosis type 1, and multiple endocrine neoplasia type 1 (MEN 1).
Differential Diagnosis
Multiple endocrine neoplasia type 2 must be differentiated from the following hereditary diseases. |}